Skip to main content
VYGR logo
VYGR
(NASDAQ)
Voyager Therapeutics, Inc.
$3.96-- (--)
Loading... - Market loading

Voyager Therapeutics (VYGR) Stock Price & Financial Analysis

Voyager Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.80 - $3.96
52-Week High$5.55
52-Week Low$2.65
Open$3.91
Volume462.51K
Average Volume (3M)462.51K
Market Cap232.42M
Shares Outstanding58.69M
Price to Sales (P/S)5.80
Price to Book (P/B)1.19
EV/EBITDA-1.74
Revenue (TTM)40.37M
Net Income (TTM)-119.72M
Free Cash Flow (TTM)-135.06M
EPS (TTM)$-2.04
Profit Margin-296.53%
Operating Margin-326.56%
Return on Equity (ROE)-61.06%
Debt to Equity0.33
50-Day MA$3.93
200-Day MA$3.95
52-Week Change18.40%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Voyager Therapeutics

What is the current stock price for VYGR?

As of the latest trading session, VYGR stock trades at $3.96. The 52-week range is $2.65–$5.55, with a day range of $3.80–$3.96.

What is the P/E ratio for VYGR?

The P/E ratio (Price-to-Earnings) for VYGR is shown in the Key Statistics section. This valuation metric helps compare Voyager Therapeutics, Inc. to industry peers.

Does VYGR pay dividends?

Voyager Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VYGR?

Based on 1 analyst, the consensus for VYGR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VYGR?

Voyager Therapeutics's market capitalization is $232.4M, classifying it as a micro-cap company. Voyager Therapeutics operates in the Healthcare sector within the Biotechnology industry.